Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesExpression of IFN-beta Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma
Cancer Research, 10/05/09
Willmon CL et al. – The enhanced therapeutic index provided by the addition of IFN–beta to VSV therefore provides a powerful justification for the development of this virus for future clinical trials.
Related Articles
Late cutaneous metastases to the face from malignant pleural mesothelioma: A case report and review of the literature
World Journal of Surgical Oncology, 11/12/09
Relevance Score: 90%
Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma
The Journal of Thoracic and Cardiovascular Surgery, 10/27/09
Relevance Score: 88%
Living with mesothelioma. A literature review
European Journal of Cancer Care, 10/27/09
Relevance Score: 87%
Tenascin-X is a Novel Diagnostic Marker of Malignant Mesothelioma
American Journal of Surgical Pathology, 10/27/09
Relevance Score: 87%
Inhibition of mesothelin–CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy
Lung Cancer, 10/01/09
Relevance Score: 85%
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiproliferative effect of exemestane in lung cancer cells
Molecular Cancer, 11/30/09
Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: Updated survival analysis of JRB-10
Journal of Clinical Oncology, 11/30/09
Skeletal morbidity in lung cancer patients with bone metastases: Demonstrating the need for early diagnosis and treatment with bisphosphonates
Lung Cancer, 11/30/09
Sponsor
Article Search
Sponsor